A detailed history of Andrew Hill Investment Advisors, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Andrew Hill Investment Advisors, Inc. holds 2,465 shares of LLY stock, worth $1.86 Million. This represents 1.75% of its overall portfolio holdings.

Number of Shares
2,465
Previous 4,907 49.77%
Holding current value
$1.86 Million
Previous $4.44 Million 50.86%
% of portfolio
1.75%
Previous 3.9%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

SELL
$772.14 - $960.02 $1.89 Million - $2.34 Million
-2,442 Reduced 49.77%
2,465 $2.18 Million
Q2 2024

Jul 15, 2024

BUY
$724.87 - $909.04 $695,875 - $872,678
960 Added 24.32%
4,907 $4.44 Million
Q1 2024

May 02, 2024

BUY
$592.2 - $792.28 $1.22 Million - $1.63 Million
2,053 Added 108.39%
3,947 $3.07 Million
Q4 2023

Jan 31, 2024

BUY
$525.19 - $619.13 $994,709 - $1.17 Million
1,894 New
1,894 $1.1 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $717B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Andrew Hill Investment Advisors, Inc. Portfolio

Follow Andrew Hill Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Andrew Hill Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Andrew Hill Investment Advisors, Inc. with notifications on news.